Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic characterization and anti-tumor effects of cytokine-induced killer cells derived from cord blood.

Cytotherapy - 1 Jan 2015

Zhang Zhen, Zhao Xianlan, Zhang Tengfei, Wang Liping, Yang Lingzhu, Huang Lan, Li Feng, Liu Jinyan, Yue Dongli, Wang Fei, Li Jieyao, Guan Fangxia, Xu Yuming, Zhang Bin, Zhang Yi

Abstract excerpt

BACKGROUND AIMS: Cytokine-induced killer (CIK) cell therapy represents a feasible immunotherapeutic option for treating malignancies. However, the number of anti-tumor lymphocytes cannot be easily obtained from the cancer patients with poor immunity status, and older patients cannot tolerate repeated collection of blood. Cord blood-derived CIK (CB-CIK) cells have shown efficacy in treating the patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis
Share to Cytotoxicity, Immunologic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fetal Blood

Share to Interferon-gamma

Share to Interleukin-2

Share to Mice, Inbred BALB C

Share to Mice, Nude

Share to Umbilical Cord

Source

Identifiers

PMID: 25457278
DOI: 10.1016/j.jcyt.2014.09.006

Genes

CCR6
CCR7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypic characterization and anti-tumor effects of cytokine-induced killer cells derived from cord blood.PMID 25457278Read ↗

The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: a clinical retrospective study.Semantic proximity Read ↗

Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors.Semantic proximity Read ↗

Cytokine induced killer cells as adoptive immunotherapy strategy to augment graft versus tumor after hematopoietic cell transplantation.Semantic proximity Read ↗

Effect of DC-CIK cell on the proliferation, apoptosis and differentiation of leukemia cells.Semantic proximity Read ↗

Biological activity of cytotoxic dendritic cells cocultured with cytokine-induced killer cells and their effect on acute leukemia cells.Semantic proximity Read ↗

Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastasesSemantic proximity Read ↗

Genetically modified and unmodified cellular approaches to enhance graft versus leukemia effect, without increasing graft versus host disease: the use of allogeneic cytokine-induced killer cellsSemantic proximity Read ↗

Multifaceted characterization of the biological and transcriptomic signatures of natural killer cells derived from cord blood and placental bloodSemantic proximity Read ↗

The phenotype of ex vivo generated cytokine-induced killer cells is associated with overall survival in patients with cancer.Semantic proximity Read ↗

Differential activation of cord blood and peripheral blood natural killer cells by cytokines.Semantic proximity Read ↗

Autologous CIK cell immunotherapy in patients with renal cell carcinoma after radical nephrectomy.Semantic proximity Read ↗

Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade cultures.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.